Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/17/26 20:34 | 3/17/26 | IRWD | Health | Drug | Pharmaceutical Preparations | Denner Alexander J | MA | D | 1 | S | -20,530 | 3.05 | 0 | -6,731 | 9,445 | M | ||||||||||||||||
2/25/26 16:05 | 2/23/26 | IRWD | Health | Drug | Pharmaceutical Preparations | John Minardo | MA | O | GC | 1 | S.m | -136 | 3.73 | 0 | -36 | 364 | D | |||||||||||||||
2/25/26 16:05 | 2/23/26 | IRWD | Health | Drug | Pharmaceutical Preparations | Shetzline Michael | MA | O | SVP,CMO, | 1 | S.m | -122 | 3.73 | 0 | -33 | 1,060 | D | |||||||||||||||
2/25/26 16:05 | 2/23/26 | IRWD | Health | Drug | Pharmaceutical Preparations | Gaskins Tammi L | MA | O | Chief Co | 1 | S.m | -80 | 3.73 | 0 | -22 | 214 | D | |||||||||||||||
2/25/26 16:05 | 2/23/26 | IRWD | Health | Drug | Pharmaceutical Preparations | McCourt Thomas A | MA | DO | CEO | 1 | S.m | -740 | 3.73 | 0 | -198 | 1,489 | D | |||||||||||||||
2/25/26 16:05 | 2/23/26 | IRWD | Health | Drug | Pharmaceutical Preparations | Martini Gregory S. | MA | O | CFO | 1 | S.m | -82 | 3.73 | 0 | -22 | 161 | D | |||||||||||||||
2/25/26 16:05 | 2/23/26 | IRWD | Health | Drug | Pharmaceutical Preparations | Silver Ronald | MA | O | Principa | 1 | S.m | -90 | 3.73 | 0 | -24 | 253 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |